Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | CA3 | P07451 | 3/20 | 0.43 |
| ▸ | CA6 | P23280 | 3/20 | 0.43 |
| ▸ | CA5A | P35218 | 3/20 | 0.43 |
| ▸ | CA7 | P43166 | 3/20 | 0.43 |
| ▸ | CA13 | Q8N1Q1 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.42 |
| ▸ | RRM2B | Q7LG56 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18770112 | 0.90 | CA12 (0.45) | NPC1RAB9ACA1CA2CA12 | |
| SCHEMBL18770140 | 0.78 | AQP1 (0.63) | NPC1RAB9ACA1CA2CA12 | |
| SCHEMBL3527661 | 0.72 | ATM (0.47) | CA1CA2CA12CA9CA3 | |
| SCHEMBL6799839 | 0.72 | NPC1 (0.57) | NPC1RAB9ACA1CA2CA12 | |
| SCHEMBL12203094 | 0.71 | RAB9A (0.54) | NPC1RAB9APTGS2PPARG | |
| SCHEMBL6797269 | 0.71 | NPC1 (0.56) | NPC1RAB9APTGS2 | |
| SCHEMBL18770125 | 0.70 | APP (0.71) | CA1CA2CA12CA9CA3 | |
| SCHEMBL7228486 | 0.69 | TSHR (0.47) | CA1CA2CA12CA9CA3 | |
| SCHEMBL12900956 | 0.69 | RAB9A (0.64) | NPC1RAB9APTGS2PPARG | |
| SCHEMBL6801599 | 0.68 | NPC1 (0.53) | NPC1RAB9ACA1CA2CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10730828-B2 | N-hydroxylsulfonamide derivatives as nitroxyl donors | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2020-08-04 | — | — | US | disclosed |
| US-20180305304-A1 | N-HYDROXYLSULFONAMIDE DERIVATIVES AS NITROXYL DONORS | THE JOHNS HOPKINS UNIVERSITY | 2018-10-25 | — | — | US | disclosed |
| EP-3365325-A1 | N-HYDROXYLSULFONAMIDE DERIVATIVES AS NITROXYL DONORS | Cardioxyl Pharmaceuticals Inc. (US) | 2018-08-29 | — | — | EP | disclosed |
| WO-2017070084-A1 | N-HYDROXYLSULFONAMIDE DERIVATIVES AS NITROXYL DONORS | CARDIOXYL PHARMACEUTICALS, INC. (US) | 2017-04-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305304-A1 | N-HYDROXYLSULFONAMIDE DERIVATIVES AS NITROXYL DONORS | TNNI3, TNNT2, TNNC1 | NPC1 518/4885RAB9A 1811/4885CA1 2720/4885 |
| US-10730828-B2 | N-hydroxylsulfonamide derivatives as nitroxyl donors | TNNI3, TNNT2, TNNC1 | NPC1 518/4885RAB9A 1811/4885CA1 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.